Should I buy or sell Transphorm stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TGAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TGAN, but not buy additional shares or sell existing shares. View TGAN analyst ratings or view top-rated stocks .

What is Transphorm's stock price target for 2024?

2 Wall Street research analysts have issued 12 month price targets for Transphorm's stock. Their TGAN share price targets range from $3.50 to $8.00. On average, they predict the company's share price to reach $5.75 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price. View analysts price targets for TGAN or view top-rated stocks among Wall Street analysts .

How have TGAN shares performed in 2024?

Transphorm's stock was trading at $3.65 at the start of the year. Since then, TGAN stock has increased by 31.5% and is now trading at $4.80. View the best growth stocks for 2024 here .

When is Transphorm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024. View our TGAN earnings forecast .

How were Transphorm's earnings last quarter?

Transphorm, Inc. (NASDAQ:TGAN) issued its earnings results on Tuesday, February, 20th. The company reported ($0.20) EPS for the quarter. The company earned $4.67 million during the quarter. Transphorm had a negative net margin of 177.91% and a negative trailing twelve-month return on equity of 149.03%.

What other stocks do shareholders of Transphorm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Transphorm investors own include Adobe (ADBE) , American Battery Technology (ABML) , Capricor Therapeutics (CAPR) , Ciena (CIEN) , Editas Medicine (EDIT) , Eros STX Global (EROS) , Grayscale Ethereum Classic Trust (ETC) (ETCG) , Freeport-McMoRan (FCX) and Franco-Nevada (FNV) .

How do I buy shares of Transphorm?

Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:TGAN

Transphorm (TGAN) Stock Price, News & Analysis

→ Special FREE offer on stock hotsheets (From DTI) (Ad)

Free TGAN Stock Alerts

$4.80

0.00 (0.00%)

(As of 04:00 PM ET)

Compare

Today's Range: $4.80
▼
$4.83
50-Day Range: $4.80
▼
$4.93
52-Week Range: $1.94
▼
$4.96

Volume: 144,864 shs
Average Volume: 405,571 shs
Market Capitalization: $303.74 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.75

Get Transphorm alerts:

Transphorm MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 19.8% Upside
$5.75 Price Target
Short Interest: Healthy
3.21% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$6,024 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.39 out of 5 stars

Computer And Technology Sector

545th out of 587 stocks

Semiconductors & Related Devices Industry

84th out of 88 stocks

2.0

Analyst's Opinion

Consensus Rating
Transphorm has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Transphorm has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.21% of the float of Transphorm has been sold short.
Short Interest Ratio / Days to Cover
Transphorm has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Transphorm has recently increased by 4.84%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Transphorm does not currently pay a dividend.
Dividend Growth
Transphorm does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TGAN.

0.0

News and Social Media Coverage

MarketBeat Follows
Only 1 people have added Transphorm to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Transphorm insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,024.00 in company stock.
Percentage Held by Insiders
Only 2.47% of the stock of Transphorm is held by insiders.
Percentage Held by Institutions
66.45% of the stock of Transphorm is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Transphorm is -6.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Transphorm is -6.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Transphorm has a P/B Ratio of 14.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Transphorm Stock (NASDAQ:TGAN)

Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.

TGAN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TGAN Stock News Headlines

April 10, 2024 | americanbankingnews.com

Transphorm (NASDAQ:TGAN) Trading 0.2% Higher

March 26, 2024 | prnewswire.com

URGENT: The M&A Class Action Firm Encourages Shareholders of Transphorm, Inc. to Take Action Before the Merger Vote on April 9, 2024 - TGAN

April 18, 2024 | Darwin (Ad)

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

March 13, 2024 | businesswire.com

TRANSPHORM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Transphorm, Inc. - TGAN

March 12, 2024 | stockhouse.com

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates JNPR, TGAN, HMST

February 20, 2024 | finance.yahoo.com

Transphorm Announces Fiscal 2024 Third Quarter Results and Provides Business Update

February 20, 2024 | businesswire.com

Transphorm Announces Fiscal 2024 Third Quarter Results and Provides Business Update

January 20, 2024 | stockhouse.com

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates JNPR, TGAN, TAST

April 18, 2024 | Darwin (Ad)

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

January 17, 2024 | finance.yahoo.com

Transphorm Announces Two 4-Lead TO-247 Devices, Expanding Product Portfolio for High Power Server, Renewable, Industrial Power Conversion

January 11, 2024 | tmcnet.com

TGAN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Transphorm, Inc. Is Fair to Shareholders

January 11, 2024 | msn.com

Renesas to buy Transphorm to expand power portfolio with GaN technology

January 11, 2024 | markets.businessinsider.com

Transphorm, Canaan And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

See More Headlines

Receive TGAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2024
Today: 4/18/2024
Next Earnings (Estimated): 6/25/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Computer and Technology
Industry: Semiconductors & related devices
Sub-Industry: N/A
Current Symbol: NASDAQ:TGAN
CUSIP: N/A
CIK: 1715768
Web: www.transphormusa.com
Phone: 805-456-1300
Fax: N/A
Employees: 128
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $5.75
High Stock Price Target: $8.00
Low Stock Price Target: $3.50
Potential Upside/Downside: +19.8%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.69)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-30,600,000.00
Net Margins: -177.91%
Pretax Margin: -177.91%
Return on Equity: -149.03%
Return on Assets: -86.65%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.69
Quick Ratio: 0.88

Sales & Book Value

Annual Sales: $16.51 million
Price / Sales: 18.40
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.33 per share
Price / Book: 14.55

Miscellaneous

Outstanding Shares: 63,280,000
Free Float: 61,712,000
Market Cap: $303.74 million
Optionable: Not Optionable
Beta: 0.58

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Primit A. Parikh Ph.D. (Age 52)
Co-Founder, President, CEO & Director
Comp: $390.66k
Mr. Cameron McAulay (Age 48)
Chief Financial Officer
Comp: $350.66k
Dr. Umesh K. Mishra Ph.D. (Age 66)
Chairman & CTO
Comp: $180k
Mr. Philip Zuk
Senior Vice President of Business Development & Marketing
Mr. Tushar Dhayagude
Vice President of Worldwide Sales & FAE
Mr. Randy Berg
Human Resources Leader
Mr. Sal Barlett
Senior Vice President of Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TGAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Transphorm stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TGAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TGAN, but not buy additional shares or sell existing shares.
View TGAN analyst ratings or view top-rated stocks.
What is Transphorm's stock price target for 2024?: 2 Wall Street research analysts have issued 12 month price targets for Transphorm's stock. Their TGAN share price targets range from $3.50 to $8.00. On average, they predict the company's share price to reach $5.75 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for TGAN or view top-rated stocks among Wall Street analysts.
How have TGAN shares performed in 2024?: Transphorm's stock was trading at $3.65 at the start of the year. Since then, TGAN stock has increased by 31.5% and is now trading at $4.80.
View the best growth stocks for 2024 here.
When is Transphorm's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024.
View our TGAN earnings forecast.

How were Transphorm's earnings last quarter?: Transphorm, Inc. (NASDAQ:TGAN) issued its earnings results on Tuesday, February, 20th. The company reported ($0.20) EPS for the quarter. The company earned $4.67 million during the quarter. Transphorm had a negative net margin of 177.91% and a negative trailing twelve-month return on equity of 149.03%.
What other stocks do shareholders of Transphorm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Transphorm investors own include Adobe (ADBE), American Battery Technology (ABML), Capricor Therapeutics (CAPR), Ciena (CIEN), Editas Medicine (EDIT), Eros STX Global (EROS), Grayscale Ethereum Classic Trust (ETC) (ETCG), Freeport-McMoRan (FCX) and Franco-Nevada (FNV).
How do I buy shares of Transphorm?: Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TGAN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial